Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?

Detalhes bibliográficos
Autor(a) principal: Peng,Ding
Data de Publicação: 2017
Outros Autores: He,Zhi-song, Li,Xue-song, Tang,Qi, Zhang,Lei, Yang,Kai-wei, Yu,Xiao-teng, Zhang,Cui-jian, Zhou,Li-qun
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Braz J Urol (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000500849
Resumo: ABSTRACT Objectives: To evaluate the prognosis of non-metastatic T3a renal cell carcinoma (RCC) with partial nephrectomy (PN). Patients and Methods: We retrospectively evaluated 125 patients with non-metastatic T3a RCC. Patients undergoing PN and radical nephrectomy (RN) were strictly matched by clinic-pathologic characteristics. Log-rank test and Cox regression model were used for univariate and multivariate analysis. Results: 18 pair patients were matched and the median follow-up was 35.5 (10-86) months. PN patients had a higher postoperative eGFR than RN patients (P=0.034). Cancer-specific survival (CSS) and recurrence-free survival (RFS) did not differ between two groups (P=0.305 and P=0.524). On multivariate analysis, CSS decreased with positive surgical margin and anemia (both P <0.01) and RFS decreased with Furhman grade, positive surgical margin, and anemia (all P<0.01). Conclusions: For patients with non-metastatic pT3a RCC, PN may be a possible option for similar oncology outcomes and better renal function.
id SBU-1_c15eb270b906ca03d36768df52048bd5
oai_identifier_str oai:scielo:S1677-55382017000500849
network_acronym_str SBU-1
network_name_str International Braz J Urol (Online)
repository_id_str
spelling Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?CarcinomaRenal CellNephrectomyPatientsABSTRACT Objectives: To evaluate the prognosis of non-metastatic T3a renal cell carcinoma (RCC) with partial nephrectomy (PN). Patients and Methods: We retrospectively evaluated 125 patients with non-metastatic T3a RCC. Patients undergoing PN and radical nephrectomy (RN) were strictly matched by clinic-pathologic characteristics. Log-rank test and Cox regression model were used for univariate and multivariate analysis. Results: 18 pair patients were matched and the median follow-up was 35.5 (10-86) months. PN patients had a higher postoperative eGFR than RN patients (P=0.034). Cancer-specific survival (CSS) and recurrence-free survival (RFS) did not differ between two groups (P=0.305 and P=0.524). On multivariate analysis, CSS decreased with positive surgical margin and anemia (both P <0.01) and RFS decreased with Furhman grade, positive surgical margin, and anemia (all P<0.01). Conclusions: For patients with non-metastatic pT3a RCC, PN may be a possible option for similar oncology outcomes and better renal function.Sociedade Brasileira de Urologia2017-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000500849International braz j urol v.43 n.5 2017reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/s1677-5538.ibju.2016.0598info:eu-repo/semantics/openAccessPeng,DingHe,Zhi-songLi,Xue-songTang,QiZhang,LeiYang,Kai-weiYu,Xiao-tengZhang,Cui-jianZhou,Li-quneng2017-11-17T00:00:00Zoai:scielo:S1677-55382017000500849Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2017-11-17T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false
dc.title.none.fl_str_mv Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
title Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
spellingShingle Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
Peng,Ding
Carcinoma
Renal Cell
Nephrectomy
Patients
title_short Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
title_full Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
title_fullStr Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
title_full_unstemmed Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
title_sort Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
author Peng,Ding
author_facet Peng,Ding
He,Zhi-song
Li,Xue-song
Tang,Qi
Zhang,Lei
Yang,Kai-wei
Yu,Xiao-teng
Zhang,Cui-jian
Zhou,Li-qun
author_role author
author2 He,Zhi-song
Li,Xue-song
Tang,Qi
Zhang,Lei
Yang,Kai-wei
Yu,Xiao-teng
Zhang,Cui-jian
Zhou,Li-qun
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Peng,Ding
He,Zhi-song
Li,Xue-song
Tang,Qi
Zhang,Lei
Yang,Kai-wei
Yu,Xiao-teng
Zhang,Cui-jian
Zhou,Li-qun
dc.subject.por.fl_str_mv Carcinoma
Renal Cell
Nephrectomy
Patients
topic Carcinoma
Renal Cell
Nephrectomy
Patients
description ABSTRACT Objectives: To evaluate the prognosis of non-metastatic T3a renal cell carcinoma (RCC) with partial nephrectomy (PN). Patients and Methods: We retrospectively evaluated 125 patients with non-metastatic T3a RCC. Patients undergoing PN and radical nephrectomy (RN) were strictly matched by clinic-pathologic characteristics. Log-rank test and Cox regression model were used for univariate and multivariate analysis. Results: 18 pair patients were matched and the median follow-up was 35.5 (10-86) months. PN patients had a higher postoperative eGFR than RN patients (P=0.034). Cancer-specific survival (CSS) and recurrence-free survival (RFS) did not differ between two groups (P=0.305 and P=0.524). On multivariate analysis, CSS decreased with positive surgical margin and anemia (both P <0.01) and RFS decreased with Furhman grade, positive surgical margin, and anemia (all P<0.01). Conclusions: For patients with non-metastatic pT3a RCC, PN may be a possible option for similar oncology outcomes and better renal function.
publishDate 2017
dc.date.none.fl_str_mv 2017-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000500849
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000500849
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1677-5538.ibju.2016.0598
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv International braz j urol v.43 n.5 2017
reponame:International Braz J Urol (Online)
instname:Sociedade Brasileira de Urologia (SBU)
instacron:SBU
instname_str Sociedade Brasileira de Urologia (SBU)
instacron_str SBU
institution SBU
reponame_str International Braz J Urol (Online)
collection International Braz J Urol (Online)
repository.name.fl_str_mv International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)
repository.mail.fl_str_mv ||brazjurol@brazjurol.com.br
_version_ 1750318075802025984